Cannara Biotech Inc logo

LOVE - Cannara Biotech Inc Share Price

C$0.11 0.0  0.0%

Last Trade - 8:22pm

Sector
Healthcare
Size
Small Cap
Market Cap £90.3m
Enterprise Value £90.8m
Revenue £1.32m
Position in Universe 553rd / 2660
Bullish
Bearish
Unlock LOVE Revenue
Momentum
Relative Strength (%)
1m +10.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -46.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Aug 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 2.10
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 29 February 2020, Cannara Biotech Inc revenues increased 16% to C$1.2M. Net loss increased 1% to C$6.2M. Revenues reflect U.S. Operations segment increase from C$0K to C$13K, U.S.Operations segment increase from C$0K to C$13K. Higher net loss reflects Canadian Operations segment loss increase of 27% to C$4.5M, U.S. Operations segment loss increase from C$458K to C$1.1M, Other segment income decrease of 65% to C$208K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LOVE Revenue Unlock LOVE Revenue

Net Income

LOVE Net Income Unlock LOVE Revenue

Normalised EPS

LOVE Normalised EPS Unlock LOVE Revenue

PE Ratio Range

LOVE PE Ratio Range Unlock LOVE Revenue

Dividend Yield Range

LOVE Dividend Yield Range Unlock LOVE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LOVE EPS Forecasts Unlock LOVE Revenue
Profile Summary

Cannara Biotech Inc. is a Canada-based vertically integrated cannabis company. The Company is focused on cultivation and manufacturing cannabis and cannabis-infused products.

Directors
Last Annual August 31st, 2019
Last Interim February 29th, 2020
Incorporated October 19, 2017
Public Since January 14, 2019
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Canadian Securities Exchange
Shares in Issue 709,970,705
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LOVE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LOVE
Upcoming Events for LOVE
Frequently Asked Questions for Cannara Biotech Inc
What is the Cannara Biotech Inc share price?

As of 8:22pm, shares in Cannara Biotech Inc are trading at C$0.11, giving the company a market capitalisation of £90.3m. This share price information is delayed by 15 minutes.

How has the Cannara Biotech Inc share price performed this year?

Shares in Cannara Biotech Inc are currently trading at C$0.11 and the price has moved by -31.25% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cannara Biotech Inc price has moved by -27.3% over the past year.

What are the analyst and broker recommendations for Cannara Biotech Inc?

There are no analysts currently covering Cannara Biotech Inc.

When will Cannara Biotech Inc next release its financial results?

Cannara Biotech Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-01
What is the Cannara Biotech Inc dividend yield?

Cannara Biotech Inc does not currently pay a dividend.

Does Cannara Biotech Inc pay a dividend?

Cannara Biotech Inc does not currently pay a dividend.

When does Cannara Biotech Inc next pay dividends?

Cannara Biotech Inc does not currently pay a dividend.

How do I buy Cannara Biotech Inc shares?

To buy shares in Cannara Biotech Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cannara Biotech Inc?

Shares in Cannara Biotech Inc are currently trading at C$0.11, giving the company a market capitalisation of £90.3m.

Where are Cannara Biotech Inc shares listed? Where are Cannara Biotech Inc shares listed?

Here are the trading details for Cannara Biotech Inc:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: LOVE
What kind of share is Cannara Biotech Inc?

Based on an overall assessment of its quality, value and momentum, Cannara Biotech Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cannara Biotech Inc share price forecast 2020?

We were not able to load any forecast data for Cannara Biotech Inc.

How can I tell whether the Cannara Biotech Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cannara Biotech Inc. Over the past six months, the relative strength of its shares against the market has been -9.84%. At the current price of C$0.11, shares in Cannara Biotech Inc are trading at -9.02% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cannara Biotech Inc PE Ratio?

We were not able to find PE ratio data for Cannara Biotech Inc.

Who are the key directors of Cannara Biotech Inc?

Cannara Biotech Inc's management team is headed by:

Zohar Krivorot - PRE
Lennie Ryer - CFO
Derek Stern - IND
Amy Satov - IND
Besar Xhelili - DRC
Thomas Faifull - IND
Who are the major shareholders of Cannara Biotech Inc?

Here are the top five shareholders of Cannara Biotech Inc based on the size of their shareholding:

Krivorot (Zohar) Individual Investor
Percentage owned: 34.25% (242.2m shares)
FSD Pharma, Inc. Corporation
Percentage owned: 12.02% (85.0m shares)
Stern (Derek Elan) Individual Investor
Percentage owned: 1.41% (10.00m shares)
Kay (Jack M) Individual Investor
Percentage owned: 0.31% (2.19m shares)
Bokhari (Raza) Individual Investor
Percentage owned: 0.26% (1.81m shares)
Similar to LOVE
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.